NCT00115947已完成2 期
Renal and Cardiovascular Effects of Terlipressin in Patients With Cirrhosis and Ascites
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 试验地点
- 2
研究概览
简要总结
The purpose of this study is to investigate the effect of terlipressin on myocardial perfusion and renal function.
Hypothesis: Significant improvement of renal function reflected by: glomerular filtration rate (GFR), renal blood flow (RBF), excretion of salt and metabolites in the urine and related hormones and peptides in the blood. No effect on the systolic function of the heart.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Crossover
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 75 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Cirrhosis and ascites
排除标准
- 未提供
研究者
研究点 (2)
Loading locations...
相似试验
进行中（未招募）
1 期
A study of the heart and kidney function during terlipressin and dobutamin treatment in patients with chronic liver disease (cirrhosis) and fluid retention (ascites)EUCTR2012-002275-33-DKDept. of Gastroenterology, Universityhospital Odense25
已完成
2 期
Effect of Terlipressin Infusion on Systemic and Hepatic Hemodynamics During Hepatobiliary SurgeryHemodynamics, Liver, TerlipressinNCT02718599Assiut University50
已完成
2 期
Effects of Terlipressin on Blood Loss and Transfusion Requirements During Major Liver Resection.Hepatectomy, Surgical Blood Loss, TerlipressinNCT02588716Assiut University84
Unknown
2 期
Terlipressin Given As I.V. Boluses Versus Terlipressin Given As Continuous Intravenous Infusion In Patients With Cirrhosis And Type 1 Hepatorenal SyndromeType 1 Hepatorenal SyndromeCirrhosisNCT00742690University of Padova70
撤回
2 期
Does Terlipressin Improve Renal Outcome After Liver SurgeryKidney FailureNCT02368249University of Zurich